Health · Public Health & Disease · 3 hrs ago
Two Men Hospitalized With Psychiatric Symptoms After Stopping Tirzepatide
Two men were hospitalized after abruptly stopping tirzepatide, a GLP-1 drug sold as Mounjaro and Zepbound.
A 61-year-old man experienced confusion, depression, paranoia and hallucinations; a 52-year-old man was diagnosed with mania.
The cases do not prove stopping the drug caused the symptoms, and both men had a history of mental health conditions.
The second man had also increased his cannabis use and had low vitamin B12, which may have contributed to his symptoms.
Researchers say the mental health effects of stopping GLP-1 drugs are not well understood, although the drugs’ receptors are also found in the brain.
The authors say prescribers should be alert to possible psychiatric symptoms after medication changes and that more research is needed.
Two men were hospitalized with psychiatric symptoms after abruptly stopping tirzepatide, according to two case studies.
One patient, aged 61, experienced confusion, depression, paranoia and hallucinations after stopping the drug because of nausea.
The other, aged 52, was diagnosed with a manic episode after stopping tirzepatide following major weight loss.
The cases do not prove that stopping the drug caused the symptoms, and both men had other potential risk factors.
The case-study authors said prescribers should be aware that recent changes to GLP-1 medication may contribute to psychiatric symptoms.
- Who
- Two men, aged 61 and 52, who had been taking tirzepatide.
- What
- Both were hospitalized with psychiatric symptoms after abruptly stopping the medication.
- When
- They presented to hospital in October 2025.
- Where
- Not stated.
- Why
- The case studies raised the possibility that stopping tirzepatide contributed to their symptoms, but do not prove causation.
This story does not have two clearly opposing sides.
The 61-year-old patient stopped tirzepatide because of nausea.
The 52-year-old patient abruptly stopped tirzepatide after losing 100 pounds over six months.
Both men presented at hospital with psychiatric symptoms.
- Patients
- Two men, aged 61 and 52
- Medication
- Tirzepatide
- First patient's reason for stopping
- Nausea
- Second patient's weight loss
- 100 pounds over six months
- Second patient's other reported factors
- Increased cannabis use and low vitamin B12 levels
What people are saying
While likely not the sole factor, it is plausible that discontinuation of a GLP-1 receptor agonist may contribute to acute-onset mood or psychotic symptoms in a select population of at-risk patients (including patients with nutritional deficiencies associated with, or exacerbated by, GLP-1 use, such as the second patient with a low vitamin B12 level)
Acute-onset mood or psychotic symptoms following GLP-1 receptor agonist discontinuation may represent an underrecognized clinical phenomenon.